Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 295

1.

How much do I give? Dose estimation formulas for once-nightly insulin glargine and premeal insulin lispro in type 1 diabetes mellitus.

King AB, Clark D, Wolfe GS.

Endocr Pract. 2012 May-Jun;18(3):382-6. doi: 10.4158/EP11312.OR.

PMID:
22440988
2.

Contribution of the dawn phenomenon to the fasting and postbreakfast hyperglycemia in type 1 diabetes treated with once-nightly insulin glargine.

King AB, Clark D, Wolfe GS.

Endocr Pract. 2012 Jul-Aug;18(4):558-62. doi: 10.4158/EP12042.OR.

PMID:
22548951
3.

How much do I give? Reevaluation of insulin dosing estimation formulas using continuous glucose monitoring.

King AB.

Endocr Pract. 2010 May-Jun;16(3):428-32. doi: 10.4158/EP09308.OR.

PMID:
20061290
4.

Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients: a prospective randomized open-label trial.

Koivisto V, Cleall S, Pontiroli AE, Giugliano D.

Diabetes Obes Metab. 2011 Dec;13(12):1149-57. doi: 10.1111/j.1463-1326.2011.01484.x.

PMID:
21819517
5.

A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study.

Bowering K, Reed VA, Felicio JS, Landry J, Ji L, Oliveira J.

Diabet Med. 2012 Sep;29(9):e263-72. doi: 10.1111/j.1464-5491.2012.03722.x. Erratum in: Diabet Med. 2012 Nov;29(11):1473. Felicio, J [corrected to Felicio, J S].

PMID:
22672081
7.

Insulin during pregnancy, labour and delivery.

de Valk HW, Visser GH.

Best Pract Res Clin Obstet Gynaecol. 2011 Feb;25(1):65-76. doi: 10.1016/j.bpobgyn.2010.10.002. Epub 2010 Dec 24. Review.

PMID:
21186142
8.

Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study.

Ruiz-de-Adana MS, Dominguez-Lopez ME, Gonzalez-Molero I, Machado A, Martin V, Cardona I, de-la-Higuera M, Tapia MJ, Soriguer F, Anarte MT, Rojo-Martínez G.

Med Clin (Barc). 2016 Mar 18;146(6):239-46. doi: 10.1016/j.medcli.2015.09.020. Epub 2015 Dec 4.

PMID:
26656958
10.

Insulin glargine dosing before next-day surgery: comparing three strategies.

Rosenblatt SI, Dukatz T, Jahn R, Ramsdell C, Sakharova A, Henry M, Arndt-Mutz M, Miller V, Rogers K, Balasubramaniam M.

J Clin Anesth. 2012 Dec;24(8):610-7. doi: 10.1016/j.jclinane.2012.02.010. Epub 2012 Nov 2.

PMID:
23122972
11.

Converting continuous insulin infusion to subcutaneous insulin glargine after cardiac surgery using percentage-based versus weight-based dosing: a pilot trial.

Silinskie KM, Kirshner R, Hite MS.

Ann Pharmacother. 2013 Jan;47(1):20-8. doi: 10.1345/aph.1Q698. Epub 2013 Jan 16.

PMID:
23324510
12.

A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.

Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV.

Diabetes Care. 2004 Jul;27(7):1554-8.

PMID:
15220227
13.

Comparison of daily glucose excursion by continuous glucose monitoring between type 2 diabetic patients receiving preprandial insulin aspart or postprandial insulin glulisine.

Ohta A, Arai K, Nishine A, Sada Y, Kato H, Fukuda H, Asai S, Nagai Y, Katabami T, Tanaka Y.

Endocr J. 2013;60(2):173-7. Epub 2012 Oct 6.

16.
17.

Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.

Karges B, Muche R, Riegger I, Moritz M, Heinze E, Debatin KM, Wabitsch M, Karges W.

Clin Ther. 2006 Dec;28(12):2094-101.

PMID:
17296465
18.

Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients.

Yanagisawa K, Ashihara J, Obara S, Wada N, Takeuchi M, Nishino Y, Maeda S, Ishibashi Y, Yamagishi S.

Diabetes Metab Res Rev. 2014 Nov;30(8):693-700. doi: 10.1002/dmrr.2537.

PMID:
24639403
19.
20.

Insulin requirement profiles in Japanese hospitalized subjects with type 2 diabetes treated with basal-bolus insulin therapy.

Shimoda S, Okubo M, Koga K, Sekigami T, Kawashima J, Kukidome D, Igata M, Ishii N, Shimakawa A, Matsumura T, Motoshima H, Furukawa N, Nishida K, Araki E.

Endocr J. 2015;62(2):209-16. doi: 10.1507/endocrj.EJ14-0487. Epub 2014 Nov 11.

Supplemental Content

Support Center